When is injectable BPC-157 a better fit?
The dose-response data show a weight effect that flattens toward the top of the range alongside dose-dependent gastrointestinal adverse events, which is consistent with a tolerability-driven choice but that reading is an inference drawn here, not a documented rationale, and Novo Nordisk has published no dose-selection statement
MT1 V MT2 This is how MT1 and MT2 compare
Liu D, Liu F, Li Z, Pan S, Xie J, Zhao Z, et al
Cse / mice on the no-Cys diet exhibited a 30% reduction in daily food intake, from 3.5 g to 2.4 g per day (Fig
[1] [2] Whilst Mounjaro typically slows gastric emptying, some patients experience diarrhoea as a side effect, which can reduce intestinal transit time